RIGL
Rigel Pharmaceuticals Inc
Price:  
19.53 
USD
Volume:  
218,305.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL EV/EBITDA

-65.9%
Upside

As of 2024-12-12, the EV/EBITDA ratio of Rigel Pharmaceuticals Inc (RIGL) is 44.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RIGL's latest enterprise value is 352.19 mil USD. RIGL's TTM EBITDA according to its financial statements is 7.88 mil USD. Dividing these 2 quantities gives us the above RIGL EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.3x - 17.8x 16.0x
Forward P/E multiples 15.7x - 23.2x 15.8x
Fair Price 5.95 - 9.94 6.66
Upside -69.5% - -49.1% -65.9%
19.53 USD
Stock Price
6.66 USD
Fair Price

RIGL EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-10 46.97
2024-12-09 52.78
2024-12-06 57.90
2024-12-05 59.20
2024-12-04 60.23
2024-12-03 61.48
2024-12-02 61.48
2024-11-29 62.73
2024-11-27 63.33
2024-11-26 60.70
2024-11-25 59.33
2024-11-22 59.22
2024-11-21 56.99
2024-11-20 55.35
2024-11-19 54.46
2024-11-18 51.85
2024-11-15 54.88
2024-11-14 62.39
2024-11-13 62.28
2024-11-12 61.86
2024-11-11 56.78
2024-11-08 50.35
2024-11-07 35.53
2024-11-06 34.73
2024-11-05 33.43
2024-11-04 32.47
2024-11-01 32.76
2024-10-31 31.49
2024-10-30 32.92
2024-10-29 33.07
2024-10-28 33.47
2024-10-25 32.67
2024-10-24 33.27
2024-10-23 33.63
2024-10-22 34.23
2024-10-21 34.12
2024-10-18 34.79
2024-10-17 34.86
2024-10-16 35.96
2024-10-15 35.22
2024-10-14 34.82
2024-10-11 35.51
2024-10-10 35.06
2024-10-09 34.79
2024-10-08 36.11
2024-10-07 35.42
2024-10-04 36.87
2024-10-03 36.89
2024-10-02 38.10
2024-10-01 37.61